The COVID-19 pandemic and cannabis use in Canada-a scoping review.
COVID-19
Canada
Cannabis
Scoping review
Journal
Journal of cannabis research
ISSN: 2522-5782
Titre abrégé: J Cannabis Res
Pays: England
ID NLM: 101752723
Informations de publication
Date de publication:
31 Jul 2023
31 Jul 2023
Historique:
received:
23
05
2022
accepted:
07
07
2023
medline:
1
8
2023
pubmed:
1
8
2023
entrez:
31
7
2023
Statut:
epublish
Résumé
Since the start of the COVID-19 pandemic in Canada, the cannabis industry has adapted to public health emergency orders which had direct and indirect consequences on cannabis consumption. The objective of this scoping review was to describe the patterns of consumption and cannabis-related health and safety considerations during the COVID-19 pandemic in Canada. For this scoping review, we searched four electronic databases supplemented with grey literature. Peer-reviewed or pre-print studies using any study design and grey literature reporting real-world data were included if published in English between March 2020 and September 2021 and focused on cannabis and COVID-19 in Canada. A content analysis was performed. Twenty-one studies met the inclusion/exclusion criteria. Study designs included cross-sectional surveys (n = 17), ecological study (n = 1), conceptual paper (n = 1), longitudinal study (n = 1), and prospective cohort study (n = 1). Most were conducted solely in Canada (n = 18), and the remaining included global data. Our content analysis suggested that cannabis consumption during the pandemic varied by reasons for use, consumers' age, gender, and method of consumption. Health and safety impacts due to the COVID-19 pandemics included increased mental illness, increased emergency visits, and psychosocial impacts. This scoping review suggested that the impact of the pandemic on cannabis consumption in Canada is more complex than simplistic assumptions of an increase or decrease in consumption and continues to be difficult to measure. This study has explored some of those complexities in relation to reasons for use, age, gender, method of consumption, and health impacts. This scoping review is limited by focusing on the breadth compared to depth. Legalizing nonmedical use of cannabis in Canada in 2018 has had its challenges of implementation, one of which has been the changing context of the society. The findings of this study can help inform cannabis policy updates in Canada as the country is reaching its fifth year of legalizing nonmedical use of cannabis.
Sections du résumé
BACKGROUND
BACKGROUND
Since the start of the COVID-19 pandemic in Canada, the cannabis industry has adapted to public health emergency orders which had direct and indirect consequences on cannabis consumption. The objective of this scoping review was to describe the patterns of consumption and cannabis-related health and safety considerations during the COVID-19 pandemic in Canada.
METHODS
METHODS
For this scoping review, we searched four electronic databases supplemented with grey literature. Peer-reviewed or pre-print studies using any study design and grey literature reporting real-world data were included if published in English between March 2020 and September 2021 and focused on cannabis and COVID-19 in Canada. A content analysis was performed.
RESULTS
RESULTS
Twenty-one studies met the inclusion/exclusion criteria. Study designs included cross-sectional surveys (n = 17), ecological study (n = 1), conceptual paper (n = 1), longitudinal study (n = 1), and prospective cohort study (n = 1). Most were conducted solely in Canada (n = 18), and the remaining included global data. Our content analysis suggested that cannabis consumption during the pandemic varied by reasons for use, consumers' age, gender, and method of consumption. Health and safety impacts due to the COVID-19 pandemics included increased mental illness, increased emergency visits, and psychosocial impacts.
DISCUSSION
CONCLUSIONS
This scoping review suggested that the impact of the pandemic on cannabis consumption in Canada is more complex than simplistic assumptions of an increase or decrease in consumption and continues to be difficult to measure. This study has explored some of those complexities in relation to reasons for use, age, gender, method of consumption, and health impacts. This scoping review is limited by focusing on the breadth compared to depth.
CONCLUSIONS
CONCLUSIONS
Legalizing nonmedical use of cannabis in Canada in 2018 has had its challenges of implementation, one of which has been the changing context of the society. The findings of this study can help inform cannabis policy updates in Canada as the country is reaching its fifth year of legalizing nonmedical use of cannabis.
Identifiants
pubmed: 37525289
doi: 10.1186/s42238-023-00196-7
pii: 10.1186/s42238-023-00196-7
pmc: PMC10388476
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
31Informations de copyright
© 2023. The Author(s).
Références
J Adolesc Health. 2020 Sep;67(3):354-361
pubmed: 32693983
Health Rep. 2020 Feb 19;31(2):11-20
pubmed: 32073644
Health Promot Chronic Dis Prev Can. 2020 Sep 16;40(11-12):342-349
pubmed: 32936071
Subst Abuse Treat Prev Policy. 2021 Apr 26;16(1):36
pubmed: 33902668
Int J Evid Based Healthc. 2015 Sep;13(3):141-6
pubmed: 26134548
Int J Psychiatry Clin Pract. 2022 Jun;26(2):148-156
pubmed: 34351841
J Stud Alcohol Drugs. 2022 May;83(3):352-357
pubmed: 35590175
Front Psychiatry. 2020 Dec 21;11:601653
pubmed: 33408655
Addict Behav. 2022 Jan;124:107092
pubmed: 34469783
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Implement Sci. 2010 Sep 20;5:69
pubmed: 20854677
J Psychiatr Res. 2021 May;137:96-103
pubmed: 33667763
Health Rep. 2021 Apr 21;32(4):3-14
pubmed: 33881274
Can J Public Health. 2020 Dec;111(6):953-962
pubmed: 33170494
Am J Public Health. 2017 Aug;107(8):e1-e12
pubmed: 28644037
Can J Psychiatry. 2022 May;67(5):403-406
pubmed: 34378420
J Addict Med. 2021 Nov-Dec 01;15(6):484-490
pubmed: 33323693
Addict Behav Rep. 2021 Mar 03;13:100341
pubmed: 33763517
Eur Addict Res. 2020;26(6):309-315
pubmed: 32961535
Int J Qual Stud Health Well-being. 2014 Oct 16;9:26152
pubmed: 25326092
Front Psychiatry. 2021 Apr 07;12:650759
pubmed: 33897499
Subst Abus. 2020;41(4):409-412
pubmed: 33044893
BMC Public Health. 2021 Jun 21;21(1):1181
pubmed: 34154564
Front Psychiatry. 2021 Aug 06;12:646206
pubmed: 34421664